References
Arrondel C, Vodovar N, Knebelmann B, Grunfeld JP, Gubler MC, Antignac C, Heidet L (2002) Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 13:65–74
Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A (2003) MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 82:203–215
Peterson LC, Rao KV, Crosson JT, White JG (1985) Fechtner syndrome-a variant of Alport’s syndrome with leukocyte inclusions and macrothrombocytopenia. Blood 65:397–406
Ghiggeri GM, Caridi G, Magrini U, Sessa A, Savoia A, Seri M, Pecci A, Romagnoli R, Gangarossa S, Noris P, Sartore S, Necchi V, Ravazzolo R, Balduini CL (2003) Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 41:95–104
Nel N, van Rensburg BW, du Plessis L, Potgieter CD, Stevens K (1992) Coincidental finding of May-Hegglin anomaly in a patient with end-stage renal failure. Am J Hematol 40:216–221
Alving BM, Tarassoff PG, Moore J, Leissenger CA, Fernandez-Bueno C (1986) Successful renal transplantation for Epstein syndrome. Am J Hematol 21:111–113
Byrne MC, Budisavljevic MN, Fan Z, Self SE, Ploth DW (2002) Renal transplant in patients with Alport’s syndrome. Am J Kidney Dis 39:769–775
Donaudy F, Snoeckx R, Pfister M, Zenner HP, Blin N, Di Stazio M, Ferrara A, Lanzara C, Ficarella R, Declau F, Pusch CM, Nürnberg P, Melchionda S, Zelante L, Ballana E, Estivill X, Van Camp G, Gasparini P, Savoia A (2004) Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4). Am J Hum Genet 74:770–776
Pecci A, Panza E, Pujol-Moix N, Klersy C, Di Bari F, Bozzi V, Gresele P, Lethagen S, Fabris F, Dufour C, Granata A, Doubek M, Pecoraro C, Koivisto PA, Heller PG, Iolascon A, Alvisi P, Schwabe D, De Candia E, Rocca B, Russo U, Ramenghi U, Noris P, Seri M, Balduini CL, Savoia A (2008) Position of non muscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat 29:409–417
Author information
Authors and Affiliations
Corresponding author
Additional information
This article refers to the article that can be found at https://doi.org/10.1007/s00467-008-0937-4.
Rights and permissions
About this article
Cite this article
Bhatt, A., Broxson, E., Witte, D. et al. Thrombocytopenia and proteinuria: answer. Pediatr Nephrol 24, 487–488 (2009). https://doi.org/10.1007/s00467-008-0938-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-008-0938-3